TA
GMED icon

TCG Advisors’s Globus Medical GMED Stock Holding History

TCG Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,403
Closed -$830K – 41
2020
Q2 		$830K Sell
17,403
-1,325
-7% -$63.9K 0.46% 66
2020
Q1 		$797K Buy
18,728
+1,225
+7% +$60.5K 0.65% 55
2019
Q4 		$1.03M Buy
+17,503
New +$950K 0.62% 52

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

TCG Advisors's GMED Position: Q3 2020 in Review

TCG Advisors sold out of Globus Medical (GMED) in Q3 2020, closing a stake of 17,403 shares — an estimated $830K sold.

TCG Advisors first reported a position in GMED in Q4 2019 and held it in 3 quarters. The position peaked at $1.03M in Q4 2019. 343 funds tracked by Wall St. Rank hold GMED as of Q3 2020.

  • TCG Advisors reported no remaining Globus Medical position as of Q3 2020 after selling out during the quarter.
  • TCG Advisors sold 17,403 Globus Medical shares in Q3 2020, an estimated $830K.
  • TCG Advisors first reported a position in Globus Medical in Q4 2019 and held it in 3 quarters.
  • TCG Advisors's Globus Medical position peaked at $1.03M in Q4 2019.
  • 343 funds tracked by Wall St. Rank held Globus Medical as of Q3 2020.

Based on TCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.